Min Cui, Decheng Capital founder
June 17, 2024 01:48 PM EDT
Financing
Startups

Life sci­ences in­vestor Decheng Cap­i­tal tar­gets $700M for fifth fund

Kyle LaHucik

Senior Reporter

Af­ter $900 mil­lion and $500-plus mil­lion fund clo­sures last week from Fore­site Cap­i­tal and JP Mor­gan, re­spec­tive­ly, an­oth­er firm wants to en­ter the up­per ech­e­lons …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times